Osimertinib after Chemoradiotherapy in Stage III <i>EGFR</i> -Mutated NSCLCShun Lu, Suresh S. Ramalingam, Terufumi Kato et al.|New England Journal of Medicine|2024Cited by 291
Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung CancerYing Jin, Ming Chen|Clinical Cancer Research|2021Cited by 115
Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cellsYang Yang, Ming Chen|Oncotarget|2014Cited by 114
RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axisMu‐En Wang, Ming Chen|Journal of Clinical Investigation|2023Cited by 100
Cancer-Associated Fibroblasts Correlate with Tumor-Associated Macrophages Infiltration and Lymphatic Metastasis in Triple Negative Breast Cancer PatientsJing Zhou, Weijie Zhang, Xiaohua Wang et al.|Journal of Cancer|2018Cited by 90